Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:37:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner was added announcing NIH website changes and noting that some content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.4%
    Check dated 2026-10-25T15:30:12.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-18T16:13:32.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, reflecting a minor site version update.
    Difference
    0.1%
    Check dated 2026-10-11T15:52:23.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.7.0 in place of v3.6.6, indicating an updated version tag for the study record.
    Difference
    0.1%
    Check dated 2026-09-20T19:27:57.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a small software revision. It does not change any study information or user-facing functionality beyond metadata.
    Difference
    0.1%
    Check dated 2026-08-30T17:20:47.000Z thumbnail image

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.